Weight Loss & MetabolicPeer Reviewed
New developments in GLP-1 agonist therapy for gestational diabetes: Systematic review on liraglutide, semaglutide, and exenatide from ClinicalTrials.gov.
Authors (1)
Fahad S AlshehriPharmacology and Toxicology Department, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia.
Medicine
Unknown
Published
Oct 13, 2025
Abstract
Abstract not available - data parsing issue resolved
Keywords
GLP-1 receptor agonistsgestational diabetes mellitusliraglutidepregnancy pharmacotherapysemaglutide
Article Metrics
Sourcepubmed
Related Research
Explore more articles in this research category to discover related studies and findings.